Adicet Bio ACET
NASDAQ ACET
$9.38 -0.11 (-1.16%)
At close: Aug 20, 2026 · 4:00 PM EDT

Adicet Bio (ACET) Other Operating Expenses (2023)

Adicet Bio (ACET) posted quarterly Other Operating Expenses of $19.5 million for Q3 2023.

Adicet Bio (ACET) Other Operating Expenses (2023) Analysis & Trends

Adicet Bio's Other Operating Expenses history runs 1 years deep, the most recent figure standing at $19.5 million for Q3 2023.

  • In Q3 2023, Other Operating Expenses changed N/A year-over-year to $19.5 million; the TTM figure through Jun 2024 stood at $19.5 million (changed N/A YoY), while the FY2025 annual figure was $466000.0, up 110.86% from the prior year.
  • Other Operating Expenses for Q3 2023 stood at $19.5 million.
  • The five-year high for Other Operating Expenses was $19.5 million in Q3 2023, with the low at $19.5 million in Q3 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 137.11 Bn 129.26 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 84.98 Bn 76.99 Bn 3.93 Bn
3 Argenx Se 64.52 Bn 59.33 Bn 1.37 Bn
4 Moderna 53.23 Bn 48.09 Bn 52.00 Mn
5 BeOne Medicines 41.23 Bn 36.14 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 30.65 Bn 27.34 Bn 992.69 Mn
7 Insmed 27.15 Bn 25.99 Bn 358.27 Mn
8 Royalty Pharma 26.98 Bn 26.14 Bn -
9 BioNTech SE 26.78 Bn 8.39 Bn 668.28 Mn
10 Adicet Bio 101.87 Mn -16.32 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2023 19.46 Mn